Indications
Cefditoren is indicated for the treatment of mild to moderate infections in adults and adolescents (12 years of age or older) caused by susceptible strains of the designated microorganisms in the conditions listed below: acute bacterial exacerbation of chronic bronchitis, community acquired pneumonia, pharyngitis, tonsillitis, and uncomplicated skin and skin-structure infections.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Cefditoren is delivered as Cefditoren Pivoxil, a broad-spectrum third-generation cephalosporin antibiotic. It is a prodrug, hydrolyzed by esterases during absorption, so the active form, Cefditoren, is what circulates in the blood. Cefditoren acts against both gram-positive and gram-negative organisms. Its bactericidal effect comes from blocking cell wall synthesis, achieved by binding to penicillin-binding proteins (PBPs). Cefditoren also holds up well against several ß-lactamases, including penicillinases and certain cephalosporinases.
Pregnancy & Breastfeeding
Pregnancy category B. No adequate, well controlled studies have been conducted in pregnant women, so Cefditoren should be used during pregnancy only if clearly needed. Animal studies show that Cefditoren passes into breast milk, so caution should be exercised when giving it to nursing mothers.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.